Review ArticleReviewsR
Risk Factors for Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation in Malignancies: Proposal for Classification
MAGDALENA DZIEDZIC, IWONA SADOWSKA-KRAWCZENKO and JAN STYCZYNSKI
Anticancer Research December 2017, 37 (12) 6551-6556;
MAGDALENA DZIEDZIC
1Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University Torun, Jurasz University Hospital 1, Bydgoszcz, Poland
IWONA SADOWSKA-KRAWCZENKO
2Department of Obstetrics and Gynecology, Collegium Medicum, Nicolaus Copernicus University Torun, Jan Biziel University Hospital 2, Bydgoszcz, Poland
3Department of Neonatology and Neonatal Intensive Care, Collegium Medicum, Nicolaus Copernicus University Torun, Jan Biziel University Hospital 2, Bydgoszcz, Poland
JAN STYCZYNSKI
1Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University Torun, Jurasz University Hospital 1, Bydgoszcz, Poland
In this issue
Anticancer Research
Vol. 37, Issue 12
December 2017
Risk Factors for Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation in Malignancies: Proposal for Classification
MAGDALENA DZIEDZIC, IWONA SADOWSKA-KRAWCZENKO, JAN STYCZYNSKI
Anticancer Research Dec 2017, 37 (12) 6551-6556;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Letermovir Prophylaxis for Cytomegalovirus Infection in Children After Hematopoietic Cell Transplantation
- Incidence of CMV Replication and the Role of Letermovir Primary/Secondary Prophylaxis in the Early Phase After Allogeneic Hematopoietic Stem Cell Transplantation - A Single Centre Study
- Impact of CMV and EBV on Immune Recovery After Allogeneic Hematopoietic Cell Transplantation in Children